-
公开(公告)号:US20210244778A1
公开(公告)日:2021-08-12
申请号:US17077770
申请日:2020-10-22
发明人: Lotta Stenman , Sampo Lahtinen
IPC分类号: A61K35/745 , A23L33/00 , C12N1/20 , A61P3/00 , A23L33/26 , A23L33/135 , A61K47/36 , C12R1/01
摘要: This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
-
公开(公告)号:US20210346439A1
公开(公告)日:2021-11-11
申请号:US16916425
申请日:2020-06-30
发明人: Lotta Stenman , Sampo Lahtinen , John Konhilas
IPC分类号: A61K35/747 , A23L33/135 , A61K35/74 , A61P9/10
摘要: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.
-
公开(公告)号:US10471110B2
公开(公告)日:2019-11-12
申请号:US15744211
申请日:2016-07-07
发明人: Lotta Stenman , Sampo Lahtinen , John Konhilas
IPC分类号: A61K35/745 , A23L33/135 , A61P9/00 , A61K35/74
摘要: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction, dilated cardiomyopathy, inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis), and congestive heart failure.
-
公开(公告)号:US20200306327A1
公开(公告)日:2020-10-01
申请号:US16954659
申请日:2018-12-18
发明人: Lotta Stenman , Markus Lehtinen , Yuejian Mao
IPC分类号: A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24
摘要: The invention relates to novel bacteria of the species Lactobacillus plantarum and to compositions comprising Lactobacillus plantarum, and methods and uses of said compositions for preventing and/or treating mental illness, symptoms affecting mental health and/or conditions associated with chronic stress, in a mammal. The invention can be applied in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of dietary and food supplements, medicaments and pharmaceuticals.
-
公开(公告)号:US20190105358A1
公开(公告)日:2019-04-11
申请号:US16090867
申请日:2017-04-06
发明人: Lotta Stenman , Sampo Lahtinen
IPC分类号: A61K35/745 , A61K47/36 , A61P3/00 , A23L33/135 , A23L33/26
摘要: This invention relates to the use of a composition comprising a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis (strain) 420 (B420), and one or more prebiotics and/or fibres, for use in increasing lean body mass in a mammal.
-
公开(公告)号:US20240115630A1
公开(公告)日:2024-04-11
申请号:US18317443
申请日:2023-05-15
发明人: Lotta Stenman , Sampo Lahtinen
IPC分类号: A61K35/745 , A23L33/00 , A23L33/135 , A23L33/26 , A61K47/36 , A61P3/00 , C12N1/20
CPC分类号: A61K35/745 , A23L33/135 , A23L33/26 , A23L33/30 , A61K47/36 , A61P3/00 , C12N1/20 , C12N1/205 , A23V2002/00 , A23V2200/3204 , A23V2200/332 , C12R2001/01
摘要: This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
-
公开(公告)号:US20240041953A1
公开(公告)日:2024-02-08
申请号:US18194313
申请日:2023-03-31
发明人: Lotta Stenman , Sampo Lahtinen , John Konhilas
IPC分类号: A61K35/747 , A23L33/135 , A61K35/74 , A61P9/10
CPC分类号: A61K35/747 , A23L33/135 , A61K35/74 , A61P9/10 , A23V2002/00 , A23V2400/181 , A23V2200/326
摘要: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.
-
公开(公告)号:US20230277608A1
公开(公告)日:2023-09-07
申请号:US17937090
申请日:2022-09-30
发明人: Lotta Stenman , Markus Lehtinen
IPC分类号: A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24
CPC分类号: A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24 , A23Y2220/63 , A23Y2220/67
摘要: The invention relates to bacteria of the species Lactobacillus paracasei and/or compositions comprising Lactobacillus paracasei for use in preventing and/or treating a mental illness, a symptom affecting mental health and/or a condition associated with chronic stress, in a mammal. The invention further relates to methods and uses of said bacteria of the species Lactobacillus paracasei and/or compositions. The invention can be applied in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of dietary and food supplements, medicaments and pharmaceuticals.
-
公开(公告)号:US20200330531A1
公开(公告)日:2020-10-22
申请号:US16954590
申请日:2018-12-18
发明人: Lotta Stenman , Markus Lehtinen
IPC分类号: A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24
摘要: The invention relates to bacteria of the species Lactobacillus paracasei and/or compositions comprising Lactobacillus paracasei for use in preventing and/or treating a mental illness, a symptom affecting mental health and/or a condition associated with chronic stress, in a mammal. The invention further relates to methods and uses of said bacteria of the species Lactobacillus paracasei and/or compositions. The invention can be applied in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of dietary and food supplements, medicaments and pharmaceuticals.
-
公开(公告)号:US20190134113A1
公开(公告)日:2019-05-09
申请号:US16090975
申请日:2017-04-06
发明人: Lotta Stenman , Sampo Lahtinen
IPC分类号: A61K35/745 , A61K47/36 , A61P3/00 , A23L33/135 , A23L33/26 , A23L33/00
摘要: This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and/or fat intake.
-
-
-
-
-
-
-
-
-